Download CalITC.org

CALITC.org
The California Israel
Technology Collaborative
8/6/2007
CALITC Mission

The California Israel Technology Collaborative is
dedicated to collaboratively promoting Israeli High
Technology in California and in the US

The Collaborative brings together students, alumni,
faculty, staff of major Israeli Universities as well as
Israeli Incubators and startup companies together
with members of the Southern California academic,
business, information services, life science,
healthcare and other high tech communities
8/6/2007
CALITC Accomplishments





SCICC Board Membership
Larta Israel Mentoring Program
Cedars Sinai Stem Cell Conference
Lecture Events
Site Visits in Israel
8/6/2007
Three Phase Growth Plan



Phase One - infrastructure implementation
Phase Two - growth
Phase Three - stability
8/6/2007
Phase One





Obtain non-profit status
Initiate web presence
Establish Board of Advisors
Develop Business Plan
Identify first sponsors
8/6/2007
Phase Two








Develop website
Expand contacts in California
Expand contacts in Israel
Initiate local lecture series
Establish online conferences to Israeli startups
Publish newsletter
Start mentor program
Find more sponsors
8/6/2007
Phase Three




Hire full time director
Establish Scientific Advisory Board
Grow paid membership
Begin investment programs
8/6/2007
Phase One - Non Profit Status


Find temporary partner
Initiate 501(c)3 paperwork
8/6/2007
Phase One - Web Presence

California vendor database – life science
companies, lawyers, accountants, VC, angel investors, banks

Israel startup database – Matimop, Israel Export
Institute, Israel Life Science Industry (ILSI), Israel Venture
Association (IVA), Israel incubator portfolio companies, Israeli
university tech transfer offices



Member database – newsletter, lecture series
Knowledge Base – online WIKI
Community calendar
8/6/2007
Phase Two – Web Presence

Mentoring application – volunteer crowd sourcing
functions, physician-startup matching program

Business enabling functions – business matching
program

Expansion of WIKI Knowledge Base
8/6/2007
Phase Three – Investment Programs




Trade missions to Israel
Site visits to Israeli startups
Israel Investment Clearing House
Investment fund
8/6/2007
CALITC Founders



Bruce Kobritz, M.S.
Eddy Jakobovits, Ph.D.
Advisory Board – Shai Aizin, MBA, Philip
Rosenthal, M.D.
8/6/2007
Bio – Bruce Kobritz

Bruce Kobritz is the Managing Director of Strategic Associates, a boutique Private Equity
and Venture Capital investment banking firm in Brentwood, California. Strategic Associates
specializes in capital formation, debt and equity capital raising, and providing financial
advisory services to biotechnology, life sciences, healthcare and medical device
companies. Previously, Mr. Kobritz has served as a Director of several Regional Investment
Banking firms providing expertise in a range of areas including: due diligence, valuation,
mergers & acquisitions, corporate restructuring, debt & equity recapitalization, and strategy
consulting. Client services include: institutional placements; business plan development
and presentations; debtor and creditor bankruptcy committee financial advisory services;
and
reorganizations.
Mr. Kobritz has been a featured speaker presented at numerous Healthcare, E-Health, and
Investment Banking conferences, from the Neuro Venture Forum in San Francisco to a
variety of national conferences in Chicago, New Orleans, Palm Springs and Washington,
D.C. He has served on the Board of Advisors for the National Managed Health Care
Congress and other organizations. His numerous publications include a chapter on
Medicare Managed Care for Thompson Financial Publications. A graduate of UCLA's
Anderson School, he has served as a judge with the Knapp Venture Forum at UCLA, a
participant in the Venture Roundtable and is a founder of the UCLAVC.ORG the School’s
Venture Capital Alumni organization. Mr. Kobritz served as the Chair of the UCLA E-health
Seminar Committee in 2000 and 2001, which planned the conference for The Healthcare
Collaborative at UCLA's School of Public Health.
8/6/2007
Bio – Eddy Jakobovits

Dr. Edward Jakobovits is founder and President of SciWeb, Inc., (http://www.sciweb.com), an Internetbased information service for life science professionals. This collection of four web sites provides industryspecific data and job related services for the biotechnology industry.
Before starting SciWeb, Dr. Jakobovits worked in the Research Department at Syva Co., the diagnostic
wing of Syntex Corp. and then Behring/Dade Diagnostics. There he led the efforts to create an improved
line of diagnostic reagents using molecular biology tools to synthesize mutated forms of bacterial reagents
critical to the main product lines of the company. These efforts led to the creation of several multi-million
dollar products in the drugs of abuse and therapeutic drug marker markets.
Previously, Dr. Jakobovits worked as the head of the Molecular Biology Group in Neurex Corp. in Menlo
Park. There he headed efforts to discover novel physiological human peptide genes. He also launched a
program to create novel therapeutic molecules for the treatment of bladder incontinence.
As a post doctoral fellow with Dr. Harold Varmus in the University of California at San Francisco, he
constructed a series of gene expression vectors and cell lines that allowed him to investigate the effects of
controlling the levels of tumor gene expression in cells. This work provided some of the first insights that
tumor genes had far reaching but reversible impacts on cell growth. He then moved to Genentech for a
post doctoral term with Dr. Arthur Levinson, where he continued to detail the impact of oncogene
expression on various cellular genes.
Dr. Jakobovits received his Ph.D. in Genetics from the Weizmann Institute of Science, in Israel where he
did research on the structure of the control elements of gene expression in mammalian viral systems.
8/6/2007
Bio – Shai Aizin

Mr. Shai Aizin, Counsel for Economic Affairs, to the Government of Israel
Economic Mission, Los Angeles Office. Mr. Aizin began his term as the Israeli
Consul for Economic Affairs in February, 2005. He came to Los Angeles from
the Ministry of Industry, Trade, and Labor. In Jerusalem, he served as the
Director of OECD and Import Policy. Prior to this, Mr. Aizin served as the
Economic Attaché to Poland from 1998-2002. Mr. Aizin has worked at the
Ministry in the Foreign Trade Administration since 1995. He holds a bachelor's
degree in both Politics and Public Affairs from the University of Miami and an
MBA degree from Heriot-Watt University, Edinburgh.
8/6/2007
Bio - Philip Rosenthal

Philip Rosenthal, M.D., is currently Director of Pediatric Hepatology, Medical
Director of the Pediatric Liver Transplant Program and a Professor of Pediatrics
and Surgery at the University of California, San Francisco (UCSF). He joined
the UCSF faculty in 1995, after serving as Professor of Pediatrics at the
University of California, Los Angeles (UCLA). Dr. Rosenthal is board certified in
Pediatrics and Pediatric Gastroenterology. He received a B.S. degree in Biology
from State University of New York at Albany and completed his medical training
at Downstate Medical Center and the Albert Einstein Medical Center in New
York, after which he completed a fellowship in pediatric gastroenterology at
UCSF. Dr. Rosenthal is a prolific author and a recipient of a number of
professional honors and awards and is committed to clinical service, research
and education. Currently, he is pursuing research on the pharmaceutical
treatment of hepatitis B and C, genetics and immunology of biliary atresia, use
of bioartificial liver support utilizing porcine hepatocytes for patients with
fulminant liver failure, as well as researching the quality of life following liver
transplantation in children.
8/6/2007